This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.
FederalRegister.gov retrieves relevant information about this document from Regulations.gov to provide users with additional context. This information is not part of the official Federal Register document.
U.S. Nuclear Regulatory Commission.
Notice of meeting.
The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 20-21, 2026. A sample of agenda items to be discussed include: a review of recent medical events; recommendations and advice to support the NRC implementation of the ADVANCE Act; recommendations on the staff's memo for licensing the use of alpha nuclides in radiopharmaceutical therapy; recommendations on the potential applications of artificial intelligence (AI) and deep learning technologies to enhance the efficiency and effectiveness of the NRC medical staff and the ACMUI; recommended best practices for the preparation of reports, including guidance on writing subcommittee reports and developing effective presentations, including Commission presentations; assessment of ACMUI membership to determine if the ACMUI would like to propose a change in membership to include an interventional radiologist; ACMUI review and recommendations regarding staff's proposed rulemaking on modernizing requirements relating to physical protection of category 1 and category 2 quantities of radioactive material rulemaking ( topic is tentative based on its rulemaking schedule); and NRC's medical radiation safety team updates.
Ms. A. Marra, email: Alessandra.Marra@nrc.gov, telephone: 301-415-2509.
The agenda is subject to change. The current agenda and any updates will be available on the ACMUI's Meetings and ( printed page 18009) Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/index.html or by emailing Ms. A. Marra at the contact information below.
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material.
Date and Time for Open Sessions: April 20, 2026, from 9:00 a.m. to 5:00 p.m. and April 21, 2026, from 10:00 a.m. to 1:15 p.m. Eastern Standard Time.
| Date | Webinar information (Microsoft Teams) |
|---|---|
| April 20, 2026 | Join: https://teams.microsoft.com/meet/27605721107301?p=NME89xbyHXSK32XAUI. Meeting ID: 276 057 211 073 01. Passcode: yF7DP3ri. |
| Call in number (audio only): +1 301-576-2978,,558206708#. Phone Conference ID: 558 206 708#. |
Public Participation: The meeting will be held as a webinar using Microsoft Teams. Any member of the public who wishes to participate in the meeting via Microsoft Teams or via phone should contact Ms. A. Marra using the information below. Members of the public should also monitor the NRC's Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates.
Conduct of the Meeting: The ACMUI Chair, Hossein Jadvar, M.D., Ph.D. will preside over the meeting. Dr. Jadvar will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an electronic copy to Ms. A. Marra using the contact information listed above. All submittals must be received by the close of business on April 13, 2026, and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public to the ACMUI will be permitted during the meeting, at the discretion of the ACMUI Chair.
3. The draft transcript and meeting summary will be available on ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html on or about May 28, 2026.
4. Persons who require special services, such as those for the hearing impaired, should notify Ms. A. Marra of their planned participation.
This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission's regulations in title 10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland, this 6th day of April, 2026.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2026-06807 Filed 4-8-26; 8:45 am]
BILLING CODE 7590-01-P